Biotin in multiple sclerosis in real world: a cohort of 50 patients

被引：0
|
作者：
Fromont, A. [1 ]
Romain, G. [2 ]
Vialatte, A. L. [1 ]
Maugest, L. [1 ]
Audry, D. [1 ]
Moreau, T. [1 ]
机构：
[1] Univ Hosp Dijon, Neurol, Dijon, France
[2] Univ Hosp Dijon, Epidemiol, Dijon, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P747
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis
    Frau, Jessica
    Coghe, Giancarlo
    Lorefice, Lorena
    Fenu, Giuseppe
    Musu, Luigina
    Cocco, Eleonora
    JOURNAL OF NEUROLOGY, 2019, 266 (06) : 1405 - 1411
  • [32] Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis
    Jessica Frau
    Giancarlo Coghe
    Lorena Lorefice
    Giuseppe Fenu
    Luigina Musu
    Eleonora Cocco
    Journal of Neurology, 2019, 266 : 1405 - 1411
  • [33] A decade of fingolimod in multiple sclerosis: Insights from a large real-world cohort study
    Gauer, L.
    Bigaut, K.
    Berger, E.
    Debouverie, M.
    Moreau, T.
    de Seze, J.
    REVUE NEUROLOGIQUE, 2023, 179 (06) : 576 - 584
  • [34] Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort
    Schurz, Natascha
    Sariaslani, Lydia
    Altmann, Patrick
    Leutmezer, Fritz
    Mitsch, Christoph
    Pemp, Berthold
    Rommer, Paulus
    Zrzavy, Tobias
    Berger, Thomas
    Bsteh, Gabriel
    EYE AND BRAIN, 2021, 13 : 59 - 69
  • [35] Real-world outcomes of teriflunomide in relapsing–remitting multiple sclerosis: a prospective cohort study
    Yao Zhang
    Hexiang Yin
    Dingding Zhang
    Yan Xu
    Bin Peng
    Liying Cui
    Journal of Neurology, 2022, 269 : 4808 - 4816
  • [36] Adverse effects of monoclonal antibodies in patients with multiple sclerosis: a real world experience
    Baklan, M.
    Tuncel, R.
    Ekmekci, O.
    Yuceyar, N.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 881 - 881
  • [37] Real-world experience of ocrelizumab in multiple sclerosis patients in latin america
    Rojas, J.
    Patrucco, L.
    Fruns, M.
    Flores-Rivera, J.
    Carnero Contentti, E.
    Galleguillos, L.
    Alonso, R.
    Cristiano, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 548 - 548
  • [38] Real-World Fingolimod efficacy and safety in Emirati patients with multiple sclerosis
    Ceccarelli, Antonia
    Mifsud, Victoria
    Elhennawy, Rawan Yasser Gaber
    Benedetti, Beatrice
    Hussain, Syed
    Samples, Stephen
    NEUROLOGY, 2019, 92 (15)
  • [39] Safety and efficacy of dimethyl fumarate in patients with multiple sclerosis - real world experience
    Chaves, C.
    Ganguly, R.
    Dionne, C.
    Camac, A.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 202 - 202
  • [40] Real world efficacy and safety profile of Ocrelizumab therapy in patients with multiple sclerosis
    Tran, V.
    Miller, P. A.
    Jarrar, R.
    Olson, J.
    Miller, T.
    Miravalle, A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 864 - 864
12345